Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.
- DOI
- 10.1016/j.breast.2026.104940
- Published
- 2026 Oct 1
- Container
- Breast (Edinburgh, Scotland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2026.104940,
title = {Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.},
author = {Mattar A and Cavalcante FP and Correa-Netto NF and Silveira I and Pavanel EB and La Scala CSK and Ziegelmann PK},
year = {2026},
journal = {Breast (Edinburgh, Scotland)},
doi = {10.1016/j.breast.2026.104940},
url = {https://doi.org/10.1016/j.breast.2026.104940}
}RIS
TY - JOUR TI - Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system. AU - Mattar A AU - Cavalcante FP AU - Correa-Netto NF AU - Silveira I AU - Pavanel EB AU - La Scala CSK AU - Ziegelmann PK PY - 2026 JO - Breast (Edinburgh, Scotland) DO - 10.1016/j.breast.2026.104940 UR - https://doi.org/10.1016/j.breast.2026.104940 ER -
APA
A, M., FP, C., NF, C., I, S., EB, P., CSK, L. S., & PK, Z. (2026). Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2026.104940
Source records
- pubmed · retrieved 2026-11-10T13:32:21.128Z